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Abstract 
Drosophila is a powerful genetic model system to study cancer. In patients, a small number of mutations 
accumulate in cells that change their growth characteristics and eventually lead to the formation of tumors. 
These tumors are clonal in origin, meaning the cancer arose from the proliferation of a single rogue cell. 
We have developed similar "clonal" cancer models in the Drosophila brain to study how tumor cells 
interact among each other and with their neighbors. To study such interactions, we need to tag the tumor 
cells and their neighboring cells. Such differentially marked clone-pairs or ‘twin-spots’ are ideal for genetic 
and biochemical analysis. In this proposal, our goal is to develop tools to manipulate either the tumor or the 
normal neighboring cells or both, and test the effect on tumor growth and progression. These studies will 
allow deeper analysis of early changes in the tumor that are precursors for the aggressive and invasive 
characteristics found later. We will use glioma – a lethal brain tumor – as the cancer type of interest, and 
will use the variety of genetic tools available in flies to generate the twin-spots using different fluorescent 
tags.  
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Abstract 
Glioma are glia-derived brain tumors that grow aggressively and ultimately result in 
patient death as there is no cure to date despite surgical and therapeutic interventions 
(radio- and chemotherapy). Many studies have shown that human diseases can be 
functionally conserved in Drosophila, thus, we have come up with experiments to 
manipulate gene expression in two cell populations that will help us understand more 
about how cells surrounding a tumor behave. We will use a Drosophila glioma model to 
study these cell-cell interactions. Establishing our experiment, we expect one population 
to grow into a glioma tumor and the other population to be comprised of cells that 
express stress-inducing genes. This will allow us to study the effects of wound-healing 
related genes to study the effects on the neighboring glioma tumors. We hypothesize 
that interclonal interactions promote tumor growth. We will combine the GAL4-UAS 
system with the Lex-AOP system to develop our twin-spot two-clone models. Preliminary 
results from Cut-lexA, Chimno-lexA, and Ey-lexA crossed with AOP-RFP, and crossing 
Cut-lexA with Reaper (which induces cell death mediated stress) shows promising 
results. To further test our hypothesis, we have devised two aims. The first aim is to 
generate a positively marked two-clone interclonal model by generating tumor growth in 
Drosophila Brain and understand the behavior of the glial cell surrounding the dead 
tumor cell. The second aim is to test interclonal tumor interactions using apoptotic and 
cytotoxic stress by dissecting larvae to determine the effect on tumor size and the 
intercolonal tumor interactions. By targeting glial cells that grow the closest in proximity 
to the tumor growth, it will allow us to understand cell behavior of the surrounding cell 
signals when the tumor cells die. 
P a g e  | 3 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
Background & Literature Review  
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1.1 Introductory Description of Glioma 
Glioma account for approximately 70% of human malignant primary brain tumors, and 
glioblastoma multiforme (GBM) is the most commonly diagnosed as adult glioma 
(World Health Organization grade IV). Current standard of care includes surgery, 
radiation, and chemotherapy, yet despite these treatments, the median survival time for 
GBM is only approximately 4.5 months (Yamada and Nakano 2012) with a 72% chance 
of recurrence in many patients (Milano et al, 2010).  
Because human disease linked genes are functionally conserved in Drosophila (Chien et 
al., 2002; Hirth, 2010; Pandey and Nichols, 2011; Read, 2011), it makes Drosophila 
melanogaster a powerful model to study cancer and other human diseases. One 
advantage of using Drosophila genetics is that it can be used to identify new genes and 
signaling pathways. Another advantage of using Drosophila is the cost – it is less 
expensive and requires less complicated cell manipulation compared to mouse model 
glioma. In addition, findings from Drosophila research e.g., drugs identified in 
Drosophila genetic screens have been proven effective in clinical trials in mammalian 
models (Dar et al., 2012; Das and Cagan, 2010; Read et al., 2005). 
The genetic tools available in Drosophila melanogaster enable us to mimic tumor growth 
that happens in humans into a fruit fly model. This genetic toolkit allows manipulation of 
gene expression using genetic mosaics to create somatic clones (Bier 2005; St Johnston, 
2009, Lee and Luo, 2001). Somatic clones are groups of cells that are genetically 
different from the surrounding normal cells, and usually show behaviors that are different 
from normal cells. For example, somatic clones can show cancer like effects by dividing 
rapidly, forming benign masses, and eventually showing changes akin to metastasis. The 
ability to generate and study the growth and progression of such tumor-forming somatic 
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mosaic clones one of the distinct advantages of the Drosophila model. These somatic 
mosaic clones can be identifies by cellular biomarkers (e.g., Green fluorescent protein, 
GFP), which allows tracking and analysis of tumor cells, and their surrounding normal 
cells. 
Somatic clones can be induced in many different Drosophila tissues to mimic different 
disease conditions, for example, the epithelial imaginal discs, the brain, the ovaries/testes 
of developing flies, and the intestinal cells of larvae or adults. Thus, many different 
disease models can be studies using the mosaic model in flies. In all cells, initially 
development happens through a strict growth control process where a pool of 
uncommitted cells is generated. As development proceeds, these cells become specialized 
through a process called differentiation into key cell types like neurons, epithelial cells, 
etc. In addition, stem cells participate in controlling growth and producing cells with 
specialized functions.   
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1.2 Glioma Development in D. melanogaster 
Drosophila brains are bilaterally symmetrical structures with a ventral nerve cord and 
two dorsal lobes (Spindler and Hartenstein, 2010) that contain neurons and glia (Apitz 
and Salecker, 2014). Therefore, we can use Drosophila glioma model to study the 
intercellular interaction between the surviving tumor cells as well as the dying cell to 
examine the molecular signals that promote glioma. Currently we induce glioma by 
activating two genes, PI3K and Ras, in Drosophila glial cells. These are fly counterparts 
of human genes commonly activated in glioma patients. Because there are ample genetic 
tools to study Drosophila, it provides an ideal model to study cell-to-cell signaling events 
and also provides the ability to dissect multi-gene interactions, identify new gene 
functions, and cell-type specific manipulation of gene expression in vivo (Kango-Singh, 
2014).   
Both in flies and humans, a pool of uncommitted cells generates stem cells in the brain 
that are referred to as Neuroblasts. These cells self-renew and produce a group of 
differentiated cells by undergoing two to three rounds of cell division to form Neurons 
and Glia, two major cell types in the brain. In flies, two types of neuroblasts are 
described. Type I neuroblasts divide to produce a Ganglion Mother Cell, which further 
divides to form 2 cells – 2 Neurons or 2 Glia or a neuron and a glia each – to form a small 
cluster of cells (Figure 1.1). Type II neuroblast cells are more clustered because they 
divide to form Interneuron cells which through additional rounds of cell division give rise 
to a larger cluster of cells. Both these neuoblast types and their descendants are found in 
the human brain as well. Hence, studying defects in growth regulation in flies can provide 
insights on human diseases like glioma.   
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Figure 1.1 Displays how the two different types of neuroblasts differentiate in 
Drosophila. Imagine obtained from: 
https://www.google.com/search?biw=1280&bih=728&tbm=isch&sa=1&ei=bL24XI3LEYiKtQWtuaCQDw&q=anatomy+of+3rd+instar+larvae+brain+lo
be&oq=anatomy+of+3rd+instar+larvae+brain+lobe&gs_l=img.3...10836.12388..12534...0.0..0.166.1137.7j4......1....1..gws-wiz-
img.wY5P42FUNzk#imgrc=DGYp0JHlmwEuUM  
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1.3 GAL4-UAS and LexA-lexAOP System 
The Gal4 and UAS (upstream activating sequence) system is a potent tool for targeting 
gene expression. In Drosophila, these components are carried in separate parental lines 
(Busson, 2007).  When combined it into one system via crossing two parental lines 
together, offspring bear both systems that can be used to activate the sequence of the gene 
of interest. In such a case, the Gal4 transcription factor that activates the transcription of 
its target genes by binding to the UAS cis-regulatory site; which controls the sequence for 
the targeted gene’s sequences (Busson, 2007). This system has been well established in 
our lab to produce tumor growth with RNAi and RasV12.  
Similar to the GAL4-UAS system, the LexA-LexAOP works the same way. Both are in 
individual parental genes. But once crossed, the offspring will carry the LexA-LexAOP 
line that enables LexA to act as a driver and bind to LexAOP to activate the transcription 
of the targeting gene (del Valle Rodriguez, Alberto et al, 2011). In this experiment, we 
used LexA-LexAOP to express Reaper expression in fruit flies.   
Creating a binary system with both Gal4-UAS and LexA-LexAOP into one fly will allow 
researchers to simultaneously perform two manipulations of gene expression in vivo (del 
Valle Rodriguez, Alberto et al, 2011). Researchers can “check whether two reporters are 
expressed in the same or different cells” by using “GAL4 to report the expression of one 
gene by driving Green Fluorescent Protein (GFP) expression and LexA to report 
expression of another gene by driving RFP expression” (del Valle Rodriguez, Alberto et 
al, 2011). This system has been done in the past, but had not been established using RNAi 
and RasV12  in combination with Reaper yet, which is one of our goals in this experiment.   
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1.4 Hypothesis and Specific Aims 
We plan to establish a method to manipulate gene expression in two cell populations. 
One population is expected to grow into a glioma tumor while the second is expected to 
comprise of cells that express stress – or wound – healing related genes to study effects 
on the neighboring glioma tumors. This will allow generation of two genetically distinct 
mosaic populations in the developing the Drosophila brain, and allow us to test our 
hypothesis that interclonal interactions promote tumor growth. We have devised two 
aims for this project: 
 
Aim 1 Generate a positively marked 2-clone interclonal model. 
Using knowledge from the preliminary data, we will make additional crosses with Cut-
lex-A and other stocks such as UAS Gal4 and LexAOP Reaper based system to generate 
tumor growth in the Drosophila brains. We will also make crosses of Cut-lexA with 
RasV12 that will introduce big tumor growth to Drosophila to try to understand the 
behavior of the glia cells surrounding the dead tumor cells. The final goal is to make: 
UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/cutlexA; repoGal4/+ larvae.  In these the 
repoGal4 will drive GFP, and activate Ras and PI3K (through UASPtenRNAi), whereas 
Cut-LexA will drive RFP and LexAOP-Reaper. 
Aim 2 Test interclonal tumor interactions using apoptotic and cytotoxic stress. 
Using antibodies as markers, we will dissect larvae of the type generated in Aim 1 to test 
(1) effect on tumor size, and (ii) interclonal tumor interactions. We hope to target those 
glia cells that grow as closest in proximity to the tumor growth that will allow us to 
further examine and understand behavior of the surrounding cells signals when the tumor 
cells die.  
P a g e  | 10 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Materials and Methods  
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2.1 Drosophila melanogaster as Model Organism 
The cost, availability, and ease of use makes Drosophila melanogaster an ideal organism 
of interest for genetic studies. Compare to other organisms such as mice, D. melanogaster 
are more cost efficient to maintain and perform experiments on. They have a quick 
generation turnover rate; metamorphoses from egg to larvae to pupa to adult within the 
span of 12 days. They also have a high fecundity rate that makes it more readily 
available. In addition, D. melanogaster has a small number of chromosomes, which 
makes it less complicated than organisms with a larger number of chromosomes to 
manipulate. D. melanogaster has many basic biological, physiological, and neurological 
properties that are conserved from human diseases, with approximately 75% of known 
human disease genes have recognizable matches in the fly genome; making them a 
powerful tool to understand disease mechanics and develop novel therapeutics (Pandey et 
al, 2011).   
Fruit flies used in this experiment were obtained from colleagues as well as from 
Bloomington, Indiana. They were maintained at 24°C room temperature and placed in 
29°C temperature when necessary. Rearing flies at this temperature increase the 
generation turnover rate compare to room temperature.   
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2.2 Tissues Specific Gene Expression Using Gal4-UAS System and LexA-LexAOP 
System 
D. melanogaster underwent many crossing schemes in order to create two lines with 
various components of Gal4-UAS system and LexA-LexAOP system that later would be 
used to combine into one line. The Gal4-UAS system, was used to co-activate the glioma-
causing gene using expressions of UAS RasV12 and UAS PteniRNAi with the Repo Gal4 
promoter/driver (Figure 2.1). The Repo Gal4 will drive the GFP and activate the RasV12 
and PI3K pathway through UAS PteniRNAi, which introduces tumor growth in the brain.  
The LexA flies underwent multiple crossing schemes conducive to creating a line with 
LexAOP Reaper that would be expressed using the LexA as a driver (Figure 2.2). The 
LexA driver created a protein that allowed it to bind to the transcriptional activator of the 
LexAOP Reaper. Once bound, the transcriptional activator is activated and thus the 
targeted gene is expressed. The targeted gene in this line is Reaper.  
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2.1 Diagram from Nature Reviews depicting the mechanism of how Gal 4-UAS system 
operates within the genome of an organism.  
 
 
 
 Gal 4/UAS System Lex A/ Lex AOP System 
Transcriptional Activator Gal 4 Lex A 
Effector  UAS Lex AOP 
2.2 Table illustrating how GAL 4/UAS and Lex A/Lex AOP works as transcriptional 
activator and effector.  
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2.3 Experimental Design 
To generate this model, we will take advantage of techniques that allow us to manipulate 
genes under different regulatory mechanisms. For example, using the Gal4-UAS system, 
we will co-activate the glioma causing genes. In our system, expression of UASRasV12 
and UASPtenRNAi with the repo GAL4 driver results in induction of glioma brain tumors 
in the developing larva. 
For this experiment, we plan to combine this system with the LexA-LexAOP system, 
which also facilitates the misexpression of genes in flies. We have tested Cut-lexA, 
Chimno-lexA, and Ey-lexA with AOP-RFP to track which cells in the fly’s brain will be 
affected. Secondly, we tested the effect of a stressed inducing gene Reaper in this system 
by crossing Cut-LexA to LexAOP Reaper. The preliminary data have shown promising 
results of detecting the Red Fluorescent Protein (RFP) biomarker in Reaper cells. 
Antibody staining revealed that out of the three LexA lines tested, Cut-lex-A had cells 
growing closest in proximity to the glial cells in the brain lobes. From there, Cut-lex-A 
was further crossed and amplified to aid in future studies. This mutant line was put 
through a specific crossing scheme with the correct phenotypic F1 flies used to continue 
in the next crosses.   
P a g e  | 15 
 
2.4 Using Immunohistochemistry as a Tool to Study Protein Expression and 
Localization in 3rd instar D. melanogaster larvae 
After achieving the desired phenotypes, either stocks or more crosses were made using 
flies from the Cut-LexA lines. Once those lines produce offspring with the phenotypes 
we seek, 3rd instar larvae were dissected, mounted, and photographed. D. melanogaster 
brain lobes are dissected and stained using standard protocols for immunohistochemistry. 
Generally, immunohistochemistry assays are used to show protein expression and 
localization.  
For the dissection process, we prepared a silicon agar plate with Phosphate Buffer Saline 
(PBS) that has a pH of 7.4 to dissect 3rd instar larvae on. The PBS provides the sample an 
isotonic solution to dissect in and it also prevents the fly from sticking to the silicon plate. 
After separating the brain lobes into 100μL of PBS and discarding the rest, the samples 
were fixed in 100μL of 8% parafamaldehyde (PFA) for 20 minutes. Then, the samples 
were transferred to an eppendorf tube with 1ml of PBST detergent (Triton). The 
eppendorf tubes were placed on the nutator for 10 minutes. PBST detergent was then 
removed using a vacuum and this washing process was repeated 2 more times. Once the 
washing is completed, if using antibodies, the primary bodies were added into the 
eppendorf tube and incubated at 4°C overnight. Antibodies were used to identify 
molecular markers staining on the brain lobes. The washing process using PBST was 
repeated 3 more times the following day. Secondary antibodies were added following the 
wash. The primary antibodies expression were detected by secondary antibodies 
containing fluorescence tagged, which shows up under the microscope. The eppendorf 
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tube were wrapped in foil and placed on the nutator for an additional 2 hours. The 
samples were then washed 3 more times before they was mounted.  
The mounting occurred on a slide under a stereomicroscope. After the samples were 
mounted, Vectashield were placed on top of the samples and topped by a cover slip. The 
cover slips were glued in place using nail polish around the perimeter of the slip to seal 
the slip in place. Images of the slides were taken at 20X using the electron microscope 
(Olympus Fluoview 100). A Z-stack image was generated by manually setting the focus 
of the starting and ending points. The Z-stack image generated by the camera took picture 
in slices, and then can be stacked/combined into one whole image.  The samples were 
then taken at 40X. At least five different samples of the same genotype were taken per 
magnification.  
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Chapter 3 
Results  
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3.1 Introduction 
Both Gal4-UAS and LexA-LexAOP systems play a crucial part in this experiment by 
providing us a means to manipulating the gene expression of the targeted gene. When 
both systems work in conjunction, we expect to have a positively marked two-clone 
interclonal model in Drosophila illustrated by cellular biomarkers such as GFP and RFP. 
Our goal was to generate such a model (UASGFP LexAOPRFP/ UASPtenRNAi; 
RasV12/cutlexA; repoGal4/+) to test interclonal tumor interaction using apoptotic and 
cytotoxic stress to determine the effect on tumor size and the intercolonal tumor 
interactions.  
 
3.2 Results 
Preliminary results (Figure 3.1) reveal the perspective LexA line growth in the brain lobe. 
We determined that Ey-LexA and Chimno-LexA lines did not have cell growth in the 
closest proximity to glial growth compared to Cut-LexA, and thus, Cut-LexA was 
selected to be the line we focused our study on. Illustrated in Figure 3.2 is an image of the 
Cut-LexA and its cell growth in perspective to glial cell growth.  
From there, we generated the following lines shown on List 3.4. Line #9 (Figure 3.3) that 
was generated shows successful differentially marked clone-pairs or “twin-spots” using 
the Gal4 and LexAOP binary system.  
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Figure 3.1 Left: Ey LexA x LexAOP Reaper; Right: Chimno-LexA x Lex AOP Reaper. 
Images obtained by: Minh Ho and Kirti Snidgha 
 
Figure 3.2 Cut LexA x LexAOP Reaper. This displays the close proximity of the Cut-
LexA line with the glial cells. The GFP represents the glial cells and the RFP represents 
the Cut-LexA cells.  Image obtained by: Minh Ho and Kirti Snidgha 
 
Figure 3.3 UAS RFP Lex AOP GFP; Cut-LexA/Cyo; Repo Gal 4/TM6B  x Ywhsflip; 
Sp/Cyo; LexAOP Reaper/TM6B  
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1. Repo Gal4 UAS GFP  
 
2. Pteni; RasV12 x Repo GFP.  
 
3. YwhsFlp; Sp/Cyo; LexAOP Reaper/TM6B 
 
4. YwhsFlp; Cut-lexA/Cyo; TM3/TM6B* 
 
5. YwhsFlp; Cut-lexA/Cyo; Lex AOP Reaper/TM6B* 
 
6. YwhsFlp; Cut-lexA/Cyo; Repo Gal4/TM6B* 
 
7. UAS Pteni; UAS Ras V12/ RasV12; Lex AOP Reaper/TM6B 
 
8. UAS RFP lex AOP GFP; Cut lexA/Cyo; RepoGal4/TM6B. 
 
9. UAS RFP Lex AOP GFP; Cut Lex A/Cyo; Repo Gal 4/TM6B  x Ywhsflip; Sp/Cyo; 
LexAOP Reaper/TM6B  
 
Table 3.4 Display stocks and crosses we generated over the span of the experiment.   
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3.3 Challenges 
Generating complex genotypes with an extensive number of steps came with multiple 
challenges. Whether it was due to contamination or unexpected results that differ from 
our expectations, we had to analyze, troubleshoot, and restart when needed. After 
generating and obtaining data for the lines mentioned above, we tried to create the final 
targeted line with the genotype of UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/Cut-
LexA; repoGal4/+ larvae. However, we had a contamination in Line #6 and lost Lines #4 
and #5 in the process, which forces us to remake those stocks. We successfully remade 
Line #6, although that cost us some time. However, when we tried to use Line #6 and 
cross it with the balancer YwhsFlp; Sp/Cyo; TM3/TM6B in a three-step process to 
regenerate Line #4 – before using Line #4 to recreate Line #5 – we encountered flies that 
had inconsistent phenotypes that require us to troubleshoot.  
For this cross, we had acquired the correct phenotype for the parental stocks. After 
crossing the parental stocks with each other, offspring (F1) with phenotypes of male, red 
eyes, curly wings, stubbles, and TM3 were to be collected in order to cross it with 
YwhsFlp; Sp/Cyo; TM3/TM6B to yield an F2 (genotype of YwshFlp; Cut- LexA/cyo; 
TM3/TM6B) that can be used to replace the lost stock of Line #4 (Table 3.4). However, 
the F1 males collected had every phenotype we sought except eye color. We kept seeing 
a mixture of red-eyed males and white-eyed males, instead of the consistent red-eyed 
males that were targeted. This step was repeated four more times, yet the F1 yield had a 
consistent mixture of red and white-eyed males. Thus, we were unable to replace Line #4 
and therefore, could not recover Line #5, preventing us from achieving the end goal: 
UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/cutlexA; repoGal4/+.  
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The generation time for Drosophila is approximately 12 days long, and thus, each time 
we repeated this experiment, it took a month to compete, with a total of four month spent 
regenerating this stock. We were only able to repeat this experiment four times within the 
time span allotted for this thesis.  
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Chapter 4 
Discussion  
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4.1 Significant results 
From the preliminary results, the Cut-LexA illustrates that it grows closest in proximity 
to the glial cells. We made Repo Gal4 UAS GFP as a control to see the amount of normal 
glial cells presented in the Gal4-UAS system. We also made Pteni; RasV12 x Repo GFP to 
visualize the amount of glial cells when tumor cells are present in the brain to use for the 
control for our second aim. While there were many crosses and stocks made from the 
experiment, the genotype that we wanted was not successfully made. However, the twin-
spots generated using the binary systems of Gal4 and LexAOP was successfully modeled, 
although the expression appeared to be weak. Thus, we were able to complete a part of 
Aim 1. Because we were unable to obtain that correct genotype, we couldn’t advance on 
to Aim 2.  
 
4.2 Expected Outcomes  
 
With more time to possibility generate the desired stock from the first aim that contains 
an overexpression of RasV12 and PtenRNAi to stimulate tumor growth in one population, 
and stimulate Reaper to cause cell death in another population of the cell, it is expected 
that the genotype modeled will allow us to study how the interclonal interaction 
influences the growth of tumors. This two-marked population can be quantified in the 
brain and we can test this interclonal interaction by controlling the tumor, surrounding 
cells, or both in the population. With the binary system, we can see where glioma is in the 
human brain and try to drive that expression.   
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 4.3 Future Research 
For the future research, we wish to generate the second aim and examine the interclonal 
interaction between tumors and neighboring cells. We also will try a different strategy 
and test it from a different LexA line such as using Chimno-LexA and Diachete-LexA. 
For this experiment, we targeted every glial cell growth in the brain by choosing Cut-
LexA. However, if we try another strategy and target the glial cells that only grow in the 
frontal area – since the expression of glioblastoma grows mainly in the frontal area of the 
brain in humans – we can use Chimno-LexA and Dichaete-LexA line instead. The 
experimental plan will be the same but we will use a different type of LexA line and 
hopefully that will allow us to successfully understand tumor growth interactions better in 
Drosophila and thus, can better understand human glioma.   
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